Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 287

1.

Broad Thinking: An Interview With Harold Kalant.

Kalant H.

J Stud Alcohol Drugs. 2017 Jan;78(1):158-165.

PMID:
27936377
2.

Points of agreement and difference: A rejoinder to Fischer et al.

Kalant H.

Int J Drug Policy. 2016 Aug;34:17-9. doi: 10.1016/j.drugpo.2016.07.006. Epub 2016 Jul 21. No abstract available.

PMID:
27498401
3.

Intravenous self-administration of alcohol in rats-problems with translation to humans.

Lê AD, Kalant H.

Addict Biol. 2017 Nov;22(6):1665-1681. doi: 10.1111/adb.12429. Epub 2016 Aug 2. Review.

PMID:
27480572
4.

A critique of cannabis legalization proposals in Canada.

Kalant H.

Int J Drug Policy. 2016 Aug;34:5-10. doi: 10.1016/j.drugpo.2016.05.002. Epub 2016 May 13.

PMID:
27292414
5.

Cannabis control policy: No rational basis yet for legalization.

Kalant H.

Clin Pharmacol Ther. 2015 Jun;97(6):538-40. doi: 10.1002/cpt.112. Epub 2015 Apr 17. No abstract available.

PMID:
25778495
6.

Cannabis in the treatment of rheumatic diseases: suggestions for a reasoned approach.

Kalant H.

J Rheumatol. 2015 Feb;42(2):146-8. doi: 10.3899/jrheum.140683. Epub 2014 Sep 1. No abstract available.

PMID:
25179852
7.

Jellinek Memorial Award 2012.

Kalant H.

Drug Alcohol Rev. 2013 Jan;32(1):109. doi: 10.1111/dar.12022. No abstract available.

PMID:
23301895
8.

Reply to the commentaries.

Kalant H.

Addiction. 2010 Jul;105(7):1154-5. doi: 10.1111/j.1360-0443.2010.02971.x. No abstract available.

PMID:
20642503
9.

Drug classification: science, politics, both or neither?

Kalant H.

Addiction. 2010 Jul;105(7):1146-9. doi: 10.1111/j.1360-0443.2009.02830.x. Epub 2010 Feb 9.

PMID:
20148796
10.

What neurobiology cannot tell us about addiction.

Kalant H.

Addiction. 2010 May;105(5):780-9. doi: 10.1111/j.1360-0443.2009.02739.x. Epub 2009 Nov 17.

PMID:
19919596
11.

Culture-bound concepts of addiction-still a potent influence.

Kalant H.

Addiction. 2008 Dec;103(12):1948-9. doi: 10.1111/j.1360-0443.2008.02365.x. No abstract available.

PMID:
19469733
12.

Drug treatment--not as useless as it seems.

Kalant H.

Addiction. 2008 May;103(5):707-8; discussion 710. doi: 10.1111/j.1360-0443.2008.02152.x. No abstract available.

PMID:
18412744
13.

Smoked marijuana as medicine: not much future.

Kalant H.

Clin Pharmacol Ther. 2008 Apr;83(4):517-9. doi: 10.1038/sj.clpt.6100497. No abstract available.

PMID:
18349871
14.

Adverse effects of cannabis on health: an update of the literature since 1996.

Kalant H.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Aug;28(5):849-63. Review.

PMID:
15363608
15.

Effect of NMDA antagonists, an NMDA agonist, and serotonin depletion on acute tolerance to ethanol.

Khanna JM, Morato GS, Kalant H.

Pharmacol Biochem Behav. 2002 May;72(1-2):291-8.

PMID:
11900799
16.

Medicinal use of cannabis: history and current status.

Kalant H.

Pain Res Manag. 2001 Summer;6(2):80-91.

PMID:
11854770
17.

Evaluating the impact of hemp food consumption on workplace drug tests.

Leson G, Pless P, Grotenhermen F, Kalant H, ElSohly MA.

J Anal Toxicol. 2001 Nov-Dec;25(8):691-8.

PMID:
11765026
18.

Taking money from the drinks industry does not necessarily set up a conflict.

Kalant H, Poikolainen K.

Addiction. 2001 Oct;96(10):1511. No abstract available.

PMID:
11599509
19.
20.

Recent research on alcohol tolerance and dependence.

Suwaki H, Kalant H, Higuchi S, Crabbe JC, Ohkuma S, Katsura M, Yoshimura M, Stewart RC, Li TK, Weiss F.

Alcohol Clin Exp Res. 2001 May;25(5 Suppl ISBRA):189S-196S. Review.

PMID:
11391070
21.

Not "Is it treatment?" but "Does it work?".

Kalant H.

Addiction. 2001 Apr;96(4):560-2; discusion 564-5. No abstract available.

PMID:
11345077
22.

Effects of food and body composition on blood alcohol curves.

Kalant H.

Alcohol Clin Exp Res. 2000 Apr;24(4):413-4. Review. No abstract available.

PMID:
10798570
23.
24.

Differentiating drugs by harm potential: the rational versus the feasible.

Kalant H.

Subst Use Misuse. 1999 Jan;34(1):25-34.

PMID:
10052388
25.

[Role of science in the formulation of social policy on drugs].

Kalant H.

C R Seances Soc Biol Fil. 1998;192(5):905-15. Review. French.

PMID:
9871803
26.

Vasopressin opposes locomotor stimulation by ethanol, cocaine and amphetamine in mice.

Chiu J, Kalant H, Lê DA.

Eur J Pharmacol. 1998 Aug 14;355(1):11-7.

PMID:
9754933
27.

Effects of moderate alcohol consumption on the central nervous system.

Eckardt MJ, File SE, Gessa GL, Grant KA, Guerri C, Hoffman PL, Kalant H, Koob GF, Li TK, Tabakoff B.

Alcohol Clin Exp Res. 1998 Aug;22(5):998-1040. Review.

PMID:
9726269
28.

Research on tolerance: what can we learn from history?

Kalant H.

Alcohol Clin Exp Res. 1998 Feb;22(1):67-76. Review.

PMID:
9514287
29.

Rapid tolerance and crosstolerance to motor impairment effects of benzodiazepines, barbiturates, and ethanol.

Khanna JM, Kalant H, Chau A, Shah G.

Pharmacol Biochem Behav. 1998 Feb;59(2):511-9.

PMID:
9477002
30.

Effect of NMDA antagonists on development of rapid tolerance to various barbiturates.

Khanna JM, Kalant H, Chau A, Shah G.

Alcohol. 1998 Jan;15(1):9-18.

PMID:
9426832
31.

Effect of lipid solubility on the development of chronic cross-tolerance between ethanol and different alcohols and barbiturates.

Khanna JM, Lê AD, Kalant H, Chau A, Shah G.

Pharmacol Biochem Behav. 1997 May-Jun;57(1-2):101-10.

PMID:
9164559
32.
33.

Good report but scanty research.

Kalant H.

Addiction. 1996 Jun;91(6):762-4; discussion 770-3. No abstract available.

PMID:
8696236
34.

Dizocilpine prevents the development of tolerance to ethanol-induced error on a circular maze test.

Rafi-Tari S, Kalant H, Liu JF, Silver I, Wu PH.

Psychopharmacology (Berl). 1996 May;125(1):23-32.

PMID:
8724445
35.
36.

Development of alcohol tolerance in the rat after a single exposure to combined treatment with arginine8-vasopressin and ethanol.

Wu PH, Liu JF, Wu WL, Lança AJ, Kalant H.

J Pharmacol Exp Ther. 1996 Mar;276(3):1283-91.

PMID:
8786561
37.
38.

Peripheral injection of arginine8-vasopressin increases Fos in specific brain areas.

Wu PH, Lança AJ, Liu JF, Man CF, Kalant H.

Eur J Pharmacol. 1995 Aug 15;281(3):263-9.

PMID:
8521909
39.

Selective involvement of central 5-HT2 receptors in the maintenance of tolerance to ethanol by arginine8-vasopressin.

Wu PH, Liu JF, Lança AJ, Kalant H.

J Pharmacol Exp Ther. 1994 Aug;270(2):802-8.

PMID:
8071872
40.

Effect of NMDA antagonists on rapid and chronic tolerance to ethanol: importance of intoxicated practice.

Khanna JM, Morato GS, Chau A, Shah G, Kalant H.

Pharmacol Biochem Behav. 1994 Jul;48(3):755-63.

PMID:
7938132
41.

Interaction between N-methyl-D-aspartate (NMDA) and serotonin (5-HT) on ethanol tolerance.

Khanna JM, Kalant H, Chau A, Shah G, Morato GS.

Brain Res Bull. 1994;35(1):31-5.

PMID:
7953754
42.

GABA and pentobarbital potentiation of chloride influx into microsacs is influenced by incubation time.

Mihic SJ, van Berckel BN, Wu PH, Kalant H.

Brain Res. 1993 Aug 13;619(1-2):319-23.

PMID:
8374787
43.

Effect of D-cycloserine on rapid tolerance to ethanol.

Khanna JM, Kalant H, Shah G, Chau A.

Pharmacol Biochem Behav. 1993 Aug;45(4):983-6.

PMID:
8415841
44.

Effect of anisomycin on the development of rapid tolerance to ethanol-induced motor impairment.

Bitrán M, Kalant H.

Pharmacol Biochem Behav. 1993 May;45(1):225-8.

PMID:
8516362
45.
46.

Blockade of chronic tolerance to ethanol by the NMDA antagonist, (+)-MK-801.

Wu PH, Mihic SJ, Liu JF, Lê AD, Kalant H.

Eur J Pharmacol. 1993 Feb 9;231(2):157-64.

PMID:
8453972
47.

Effect of NMDA receptor antagonists on rapid tolerance to ethanol.

Khanna JM, Shah G, Weiner J, Wu PH, Kalant H.

Eur J Pharmacol. 1993 Jan 5;230(1):23-31.

PMID:
8428601
48.

Inhibition of nitric oxide synthesis impairs rapid tolerance to ethanol.

Khanna JM, Morato GS, Shah G, Chau A, Kalant H.

Brain Res Bull. 1993;32(1):43-7.

PMID:
8319102
49.

Problems in the search for mechanisms of tolerance.

Kalant H.

Alcohol Alcohol Suppl. 1993;2:1-8. Review.

PMID:
7748283
50.

Supplemental Content

Loading ...
Support Center